netFormulary
 Report : A-Z HCD items in Formulary 05/03/2021 19:13:12
[Back]
 
Section Status HCD Name
08.03.04.02 Restricted Use Cancer Drugs Fund Abiraterone Actetate  Zytiga®
13.05.03 Restricted Use Cancer Drugs Fund Adalimumab Humira® Amgevita®
13.05.03 Restricted Use Cancer Drugs Fund Apremilast Otezla®
08.02.03 Restricted Use Cancer Drugs Fund Atezolizumab Tecentriq®
08.02.03 Restricted Use Cancer Drugs Fund Blinatumomab Blincyto®
08.02.03 Restricted Use Cancer Drugs Fund Brentuximab vedotin Adcetris®
08.02 Formulary Cancer Drugs Fund Brigatinib Alunbrig®
13.05.03 Formulary Cancer Drugs Fund Brodalumab Kyntheum®
03.04.03 Formulary Cancer Drugs Fund C1 Esterase Inhibitor Berinert®
08.02.03 Formulary Cancer Drugs Fund Daratumumab Darzalex®
13.05.03 Restricted Use Cancer Drugs Fund Dimethyl fumarate Skilarence®
13.05.03 Restricted Use Cancer Drugs Fund Dupilumab Dupixent®
08.02.03 Restricted Use Cancer Drugs Fund Durvalumab Imfinzi®
09.01.04 Restricted Use Cancer Drugs Fund Eltrombopag Revolade®
08.03.04.02 Restricted Use Cancer Drugs Fund Enzalutamide Xtandi®
13.05.03 Restricted Use Cancer Drugs Fund Etanercept Enbrel®
13.05.03 Restricted Use Cancer Drugs Fund Etanercept Benepali®
04.07.04.02 Restricted Use Cancer Drugs Fund Fremanezumab Ajovy®
08.02 Formulary Cancer Drugs Fund Gilteritinib Xospata®
13.05.03 Restricted Use Cancer Drugs Fund Guselkumab Tremfya®
03.04.03 Formulary Cancer Drugs Fund Icatibant Firazyr®
13.05.03 Restricted Use Cancer Drugs Fund Infliximab Remicade® or Inflectra ®
08.02.03 Restricted Use Cancer Drugs Fund Inotuzumab ozogamicin Besponsa®
08.02.03 Restricted Use Cancer Drugs Fund Isatuximab Sarclisa®
13.05.03 Restricted Use Cancer Drugs Fund Ixekizumab Taltz®
08.01 Non Formulary Cancer Drugs Fund Lorlatinib Lorviqua®
08.02 Formulary Cancer Drugs Fund Lorlatinib Lorviqua®
08.02.03 Restricted Use Cancer Drugs Fund Obinutuzumab Gazyvaro®
08.02.03 Restricted Use Cancer Drugs Fund Ocrelizumab Ocrevus®
08.02.03 Restricted Use Cancer Drugs Fund Ofatumumab Arzerra®
03.04.02 Restricted Use Cancer Drugs Fund Omalizumab Xolair®
08.02 Formulary Cancer Drugs Fund Osimertinib Tagrisso®
09.01.04 Restricted Use Cancer Drugs Fund Romiplostim Nplate®
08.02 Formulary Cancer Drugs Fund Rucaparib Rubraca®
13.05.03 Restricted Use Cancer Drugs Fund Secukinumab 
06.06.01 Restricted Use Cancer Drugs Fund Teriparatide Forsteo®
06.06.01 Formulary Cancer Drugs Fund Teriparatide Terrosa®
13.05.03 Restricted Use Cancer Drugs Fund Tildrakizumab Ilumetri®
01.05.03 Formulary Cancer Drugs Fund Ustekinumab Stelara®
13.05.03 Restricted Use Cancer Drugs Fund Ustekinumab Stelara®
The Mid Yorkshire Hospitals